Promega’s top-down adoption of ChatGPT accelerates manufacturing, sales, and marketing
OpenAI
Promega, a biotech manufacturer, rolled out ChatGPT company-wide from the top down. It's now speeding up production, sales, and marketing work across the whole business.
Based on reporting by OpenAI — read the original for the full story.
Summary, retelling and take written by AI under human oversight; images are AI-generated illustrations. How we work · Report an error
Promega isn't a household name, but it makes the reagents and kits that biotech and forensic labs rely on every day. So when a company like that decides ChatGPT is worth pushing into every department, it says something about where AI adoption is actually heading — not through some scrappy skunkworks team, but from leadership on down.
That top-down approach matters here. A lot of companies let AI tools trickle in through individual employees who happen to be curious, and adoption stays patchy for years. Promega instead made ChatGPT part of how manufacturing, sales, and marketing teams operate, which meant fewer holdouts and faster payback. When the people running the company use a tool and expect others to use it too, the awkward experimentation phase gets compressed into weeks instead of dragging into quarters.
The results show up in unglamorous but telling places. Manufacturing teams are using it to speed up documentation and process work that used to eat hours. Sales and marketing staff are leaning on it to draft materials and respond to customers faster, which in a specialized field like life-science reagents is not trivial — a lot of that content requires technical precision, not just fluent prose. Getting a chatbot to handle the first draft of something scientifically dense and still keep it accurate is a real test.
None of this is flashy. There's no new product launch, no research breakthrough, no dramatic headline. But that's sort of the point — this is what AI adoption looks like when it moves past the demo stage and into the actual plumbing of a mid-sized manufacturer. Promega's story is a small case study in how generative AI spreads through an organization once executives decide it's not optional.
My take — AI-written commentary, not fact-checked reporting
I'll say the quiet thing: OpenAI publishing case studies like this is marketing, plain and simple, and I don't hold that against them — but treat the productivity numbers as a highlight reel, not an audit. The real signal here isn't the tool, it's the management choice: mandate from the top beats grassroots enthusiasm every time, and that's a pattern worth stealing regardless of which chatbot you pick.
Read more about this at: OpenAI